This webinar focused on delivering personalised, supportive cancer care in melanoma, centring on quality of life for people with stage III and IV melanoma. It explained why it is important to consider the impact of treatment on quality of life in different treatment settings, and explored how models of care can be changed to better address quality-of-life issues for individual patients. The session gave an overview of health-related quality of life and how different treatments may affect patients in different ways, highlighting the melanoma specialist nurse's role in personalised, supportive cancer care and equipping nurses with the knowledge to support people with melanoma through their treatment.
Watch on demand
Event recording
Recording guide
Explore the topics
Open the guide below to see the seven topics covered, then select any topic to open the recording at that point on YouTube in a new tab.
Show the 7 topicsHide the topics
Learning outcomes
What you will learn
After this session, nurses will be able to:
01
Consider quality of life in treatment
Understand why it is important to consider the impact of different treatments for melanoma on quality of life.
02
Identify how treatments affect wellbeing
Identify how health-related quality of life can be affected by different treatments.
03
Personalise care through models of care
Understand how models of care can be used to personalise cancer care in melanoma.
04
Strengthen the specialist nurse's role
Enhance the specialist melanoma nurse's role in assessing and addressing unmet needs to facilitate personalised, supportive cancer care.
At a glance
The event in brief
Originally held
Thursday 15 January 2026
Online webinar, part of the National Melanoma Nursing Program.
Who this is for
Nurses
Nurses supporting people with melanoma through their treatment.
Contributors
Speaker
Speaker
Dr Julia Lai-Kwon
Medical Oncologist and Health Services Researcher, Peter MacCallum Cancer Centre
Dr Julia Lai-Kwon is a Medical Oncologist and Health Services Researcher at Peter MacCallum Cancer Centre, Melbourne, Australia. She has previously trained at the Royal Marsden Hospital, United Kingdom, and Melanoma Institute Australia in Sydney, Australia. Her clinical interests are melanoma and other cutaneous malignancies. Dr Lai-Kwon has research expertise in quality of life research, survivorship and patient-reported outcomes. She has presented nationally and internationally and published on the survivorship experience of people with metastatic cancers receiving immunotherapy and targeted therapy, quality of life issues in people with metastatic melanoma, and the use of patient-reported outcomes in clinical trials and routine care. She has completed a PhD under the supervision of Prof Michael Jefford, A/Prof Claudia Rutherford and A/Prof Stephanie Best on the co-design of remote symptom monitoring for people receiving immune checkpoint inhibitors. Dr Lai-Kwon is an active member of the EORTC Quality of Life Group, the International Society for Quality of Life Research (ISOQOL), and the Multinational Association for Supportive Care in Cancer (MASCC).
This webinar was brought to you by
Resource details
